GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

Preaxia Health Care Payment Systems PAXH · USD

N/A · US listing · 🇺🇸 United States

Compare

0.22

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Popular Bitcoin Ethereum Nvidia Apple S&P 500 Gold EUR/USD US 10Y

At a glance

Figures in USD, from our data supplier.

FY2026

Revenue

—

FY2017FY2026

Net income

−$1.2m

FY2017FY2026

Free cash flow

−$442,736

FY2017FY2026

Shareholders' equity

−$383,567

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue———$27$368$411————
Gross profit−$16,732———$368$411————
Research and development$307,605—$5,632$6,528$25,642$8,219$11,614$26,873$38,067$54,743
Operating income−$992,700−$152,124−$99,449−$156,266−$180,643−$163,193−$171,666−$197,799−$201,716−$249,403
Net income−$1.2m−$53,687−$99,449−$156,266−$180,643−$163,193−$171,666−$197,799−$201,716−$262,000
Diluted earnings per share-0.03-0.00-0.01-0.01-0.01-0.01-0.01-0.01-0.01-0.01

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets$583,613−$7,825$14$6$259$40$46$17,939$7,608$8,779
Cash and short-term investments$1,003—$14$6$259$40$46$17,939$7,608$8,779
Total liabilities$967,180$2.3m$2.4m$2.3m$2.1m$2.0m$1.8m$1.7m$1.4m$1.2m
Debt$114,106$1.7m$1.7m$1.7m$1.7m$1.2m$1.2m$1.2m$1.1m$17,280
Shareholders' equity−$383,567−$2.3m−$2.4m−$2.3m−$2.1m−$2.0m−$1.8m−$1.7m−$1.4m−$1.2m
Shares outstanding45m44m20m20m20m20m20m20m20m20m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations−$121,155−$41,516−$30,888−$37,617−$63,971−$35,717−$30,551−$86,222−$70,955−$118,385
Capital spending−$321,581—————————
Free cash flow−$442,736−$41,516−$30,888−$37,617−$63,971−$35,717−$30,551−$86,222−$70,955−$118,385

Latest quarters

By quarter end

Aug 2026May 2026Feb 2026Nov 2025Aug 2025May 2025Feb 2025Nov 2024
Gross profit−$16,732———————
Operating income−$209,852−$209,852−$94,659−$112,055−$875,203−$13,463−$13,463−$13,666
Net income−$210,109−$210,109−$94,334−$111,820−$875,134−$13,463−$13,463−$13,666
Diluted earnings per share-0.00-0.00-0.00-0.00-0.02-0.00-0.00-0.00
Total assets$583,613$583,613$442,780$143,636$1.2m$3$3$165
Cash and short-term investments$1,003—$57,330—$130,285$3—$165
Debt$114,106—$163,252—$89,784$1.7m—$1.7m
Shareholders' equity−$383,567−$383,567−$364,051−$625,129−$3.2m−$2.4m−$2.4m−$2.4m

Growth per year

Compound annual rate

3 years5 years10 years
Operating income85.2%43.5%15.5%
Net income95.2%48.1%15.9%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings-8.5-178.3-4.2-2.6-2.3-2.0-1.4-0.6-0.6-0.4

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return532%67%1%26%39%100%0%0%400%0%

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.